Mini Review
Progress in knowledge of Alzheimer’s disease
Julio López Argüelles1*, Dra Leydi M Sosa Aguila2, Lic Aleima B Rodriguez Carbajal3 and Lisan Montalvo Manso1
1Department of Neurology, University Hospital Gustavo Aldereguía Lima, Cuba
2Genetic Center, University Hospital Paquito González Cueto, Cuba
3Department of Neuropsychology, University Hospital Gustavo Aldereguía Lima, Cuba
Julio López Argüelles, Department of Neurology, University Hospital Gustavo Aldereguía Lima, Cuba.
Received Date: July 25, 2019; Published Date: July 29, 2019
Abstract
In the old age increase the frequencies of mental disease such as primary dementias, being presented most frequently Alzheimer´s Disease and vascular dementia. The principal progress is based on the determination of the early presence of changes in the patients genetically predisposed to suffer from Alzheimer’s disease, studies endorsed by a monitoring to patients with mutations from 1 to 3 genes associated with Alzheimer’s disease of early appearance. For first time we got a chronological table of the events that indicate the need for early intervention, with available biological markers that can be measured in order to evaluate the effects of the pharmacotherapy.
Keywords:Dementia; Alzheimer´s disease; Biological marker; Beta protein amyloide
-
Julio López Argüelles, Dra Leydi M Sosa Aguila, Lic Aleima B Rodriguez Carbajal, Lisan Montalvo Manso. Progress in knowledge of Alzheimer’s disease. Arch Neurol & Neurosci. 4(3): 2019. ANN.MS.ID.000589.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.